BCG Tuberculosis (TB) Vaccine Market Report

Global BCG Tuberculosis (TB) Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：230
  • REPORT CODE：GMM825650
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • BCG Tuberculosis (TB) Vaccine market report explains the definition, types, applications, major countries, and major players of the BCG Tuberculosis (TB) Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Intervax

    • Sanofi Pasteur

    • Japan BCG Lab

    • China National Biotec

    • Merck

    • GSBPL

    • Serum Institute of India

    By Type:

    • Immune BCG

    • Therapy BCG

    By End-User:

    • Hospital

    • Clinic

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global BCG Tuberculosis (TB) Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 BCG Tuberculosis (TB) Vaccine Outlook to 2028- Original Forecasts

    • 2.2 BCG Tuberculosis (TB) Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term BCG Tuberculosis (TB) Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global BCG Tuberculosis (TB) Vaccine Market- Recent Developments

    • 6.1 BCG Tuberculosis (TB) Vaccine Market News and Developments

    • 6.2 BCG Tuberculosis (TB) Vaccine Market Deals Landscape

    7 BCG Tuberculosis (TB) Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials

    • 7.2 BCG Tuberculosis (TB) Vaccine Price Trend of Key Raw Materials

    • 7.3 BCG Tuberculosis (TB) Vaccine Key Suppliers of Raw Materials

    • 7.4 BCG Tuberculosis (TB) Vaccine Market Concentration Rate of Raw Materials

    • 7.5 BCG Tuberculosis (TB) Vaccine Cost Structure Analysis

      • 7.5.1 BCG Tuberculosis (TB) Vaccine Raw Materials Analysis

      • 7.5.2 BCG Tuberculosis (TB) Vaccine Labor Cost Analysis

      • 7.5.3 BCG Tuberculosis (TB) Vaccine Manufacturing Expenses Analysis

    8 Global BCG Tuberculosis (TB) Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global BCG Tuberculosis (TB) Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global BCG Tuberculosis (TB) Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global BCG Tuberculosis (TB) Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immune BCG Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapy BCG Consumption and Growth Rate (2017-2022)

    • 9.2 Global BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise BCG Tuberculosis (TB) Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.2.2 Canada BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.2 UK BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.3 Spain BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.5 France BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.6 Italy BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.8 Finland BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.9 Norway BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.11 Poland BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.12 Russia BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.2 Japan BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.3 India BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.3 Chile BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.6 Peru BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.6.3 Oman BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand BCG Tuberculosis (TB) Vaccine Consumption (2017-2022)

    11 Global BCG Tuberculosis (TB) Vaccine Competitive Analysis

    • 11.1 Intervax

      • 11.1.1 Intervax Company Details

      • 11.1.2 Intervax BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Intervax BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.1.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi Pasteur

      • 11.2.1 Sanofi Pasteur Company Details

      • 11.2.2 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Japan BCG Lab

      • 11.3.1 Japan BCG Lab Company Details

      • 11.3.2 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 China National Biotec

      • 11.4.1 China National Biotec Company Details

      • 11.4.2 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Merck

      • 11.5.1 Merck Company Details

      • 11.5.2 Merck BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Merck BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.5.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 GSBPL

      • 11.6.1 GSBPL Company Details

      • 11.6.2 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 GSBPL BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.6.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Serum Institute of India

      • 11.7.1 Serum Institute of India Company Details

      • 11.7.2 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

      • 11.7.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global BCG Tuberculosis (TB) Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Immune BCG Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Therapy BCG Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise BCG Tuberculosis (TB) Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand BCG Tuberculosis (TB) Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of BCG Tuberculosis (TB) Vaccine

    • Figure of BCG Tuberculosis (TB) Vaccine Picture

    • Table Global BCG Tuberculosis (TB) Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global BCG Tuberculosis (TB) Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Immune BCG Consumption and Growth Rate (2017-2022)

    • Figure Global Therapy BCG Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Table North America BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure United States BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure Germany BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure China BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure Brazil BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania BCG Tuberculosis (TB) Vaccine Consumption by Country (2017-2022)

    • Figure Australia BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand BCG Tuberculosis (TB) Vaccine Consumption and Growth Rate (2017-2022)

    • Table Intervax Company Details

    • Table Intervax BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intervax BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Table Japan BCG Lab Company Details

    • Table Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Japan BCG Lab BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Table China National Biotec Company Details

    • Table China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Table Merck Company Details

    • Table Merck BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table Merck BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Table GSBPL Company Details

    • Table GSBPL BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSBPL BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Table Serum Institute of India Company Details

    • Table Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India BCG Tuberculosis (TB) Vaccine Main Business and Markets Served

    • Table Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio

    • Figure Global Immune BCG Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapy BCG Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania BCG Tuberculosis (TB) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand BCG Tuberculosis (TB) Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US